We were able to rank most of the psychotropics based on the available evidence and recommendations from subject matter experts .
There were few discrepancies between published evidence and the expert panel in ranking these drugs .
Conclusion Potential for weight gain is an important consideration in choice of any psychotropic .
This tool will help clinicians select psychotropics on a case-by-case basis in order to minimize the impact of weight gain when making both intra-class and interclass choices
Introduction Psychotropic medication use is associated with  weight gain .
While there are studies and review s comparing weight gain for psychotropics within some classes , clinicians frequently use drugs from different classes to treat psychiatric disorders .
Objective To undertake a systematic review of all classes of psychotropics to provide an all encompassing evidence -based tool that would allow clinicians to determine the risks of weight gain in making both intra-class and interclass choices of psychotropics .
Attitudes about Antidepressants: Influence of Information about Weight-Related Side Effects
Antidepressant drugs are frequently prescribed for women and have various side effects , including potential effects on body weight . This experiment examined the effects of information about the weight-related side effects of antidepressants on  women 's attitudes toward the drugs . 60 college women were r and omly assigned to read about one of two drugs , fluoxetine ( Prozac ) or Imipramine ( Tofranil ) . Participants were either told or not told about veridical weight-related side effects , namely , weight loss for Prozac and weight gain for Tofranil . As hypothesized , weight-gain information lowered the personal acceptability of Tofranil , and weight-loss information enhanced the acceptability of Prozac . Although research with clinical population s is required , undergraduate women 's decisions about the use of antidepressant medications may be influenced by societal body-image ideals
We were able to rank most of the psychotropics based on the available evidence and recommendations from subject matter experts .
There were few discrepancies between published evidence and the expert panel in ranking these drugs .
Conclusion Potential for weight gain is an important consideration in choice of any psychotropic .
This tool will help clinicians select psychotropics on a case-by-case basis in order to minimize the impact of weight gain when making both intra-class and interclass choices
Introduction Psychotropic medication use is associated with  weight gain .
While there are studies and review s comparing weight gain for psychotropics within some classes , clinicians frequently use drugs from different classes to treat psychiatric disorders .
Objective To undertake a systematic review of all classes of psychotropics to provide an all encompassing evidence -based tool that would allow clinicians to determine the risks of weight gain in making both intra-class and interclass choices of psychotropics .